5:11 pm Durata Therapeutics confirms FDA Advisory Committee unanimously recommends approval of Dalvance for the treatment of acute bacterial skin and skin structure infections (stock halted)
View todays social media effects on DRTX
View the latest stocks trending across Twitter. Click to view dashboard
See who Durata is hiring next, click here to view
